Butterfly Network (BFLY) Shares Outstanding (Weighted Average) (2019 - 2026)
Butterfly Network's (BFLY) quarterly Shares Outstanding (Weighted Average) came in at $256.5 million in Q1 2026, up 9.19% year-on-year from $234.9 million in Q1 2025, and up 3.8% quarter-over-quarter from $247.1 million in Q4 2025.
Butterfly Network (BFLY) Shares Outstanding (Weighted Average) (2019 - 2026) Analysis & Trends
Butterfly Network has disclosed Shares Outstanding (Weighted Average) across 8 years of filings, most recently posting $256.5 million for Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $256.5 million, up 9.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $256.5 million (up 9.19% YoY), and the FY2025 annual result was $247.1 million, up 16.74% from the prior year.
- Shares Outstanding (Weighted Average) came in at $256.5 million for Q1 2026 at Butterfly Network, up from $247.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $256.5 million in Q1 2026 to a low of $199.0 million in Q1 2022.
- The 5-year median for Shares Outstanding (Weighted Average) is $208.9 million (2024), against an average of $216.6 million.
- Across the five-year window, Shares Outstanding (Weighted Average) surged 87.88% in 2022 and climbed 1.79% in 2023, its largest moves.
- Butterfly Network's Shares Outstanding (Weighted Average) stood at $199.8 million in 2022, then climbed by 2.77% to $205.4 million in 2023, then increased by 3.07% to $211.7 million in 2024, then grew by 16.74% to $247.1 million in 2025, then rose by 3.8% to $256.5 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $256.5 million (Q1 2026), $247.1 million (Q4 2025), and $245.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 579.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 456.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 385.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Butterfly Network | 1.42 Bn | 1.28 Bn | 18.29 Mn | 256.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 256.52 Mn |
| Dec 31, 2025 | 247.12 Mn |
| Sep 30, 2025 | 245.20 Mn |
| Jun 30, 2025 | 241.70 Mn |
| Mar 31, 2025 | 234.92 Mn |
| Dec 31, 2024 | 211.68 Mn |
| Sep 30, 2024 | 211.11 Mn |
| Jun 30, 2024 | 210.27 Mn |
| Mar 31, 2024 | 208.87 Mn |
| Dec 31, 2023 | 205.39 Mn |
| Sep 30, 2023 | 204.75 Mn |
| Jun 30, 2023 | 203.74 Mn |
| Mar 31, 2023 | 202.57 Mn |
| Dec 31, 2022 | 199.85 Mn |
| Sep 30, 2022 | 200.17 Mn |
| Jun 30, 2022 | 199.40 Mn |
| Mar 31, 2022 | 199.00 Mn |
| Dec 31, 2021 | 173.81 Mn |
| Sep 30, 2021 | 165.66 Mn |
| Jun 30, 2021 | 149.29 Mn |